{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:20:34Z","timestamp":1770538834209,"version":"3.49.0"},"reference-count":51,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The functions of mast cells in human graft-versus-host disease (GVHD) are unknown. We studied 56 patients who had an allogeneic hematopoietic cell transplantation (alloHCT) with a biopsy for diagnosis of gastrointestinal tract (GIT) GVHD before any treatment (including steroids): 35 with GIT GVHD, 21 HCT recipients whose biopsies did not confirm GVHD, and 9 with a new diagnosis of inflammatory bowel disease (IBD) as a comparison. The median number of mast cells (mean of CD117+ cells, counted in 3 selected spots under 40\u00d7 magnification) was similar between patients with GVHD (59 cells) and those without GVHD (60 cells). However, the median number of mast cells was significantly associated with maximum clinical stage of GIT GVHD; the lowest counts of mast cells were observed in the highest clinical stage of GIT GVHD (stage 1, 80; stage 2, 69; stage 3, 54; stage 4, 26; P = .01). Moreover, every decrease by 10 mast cells was associated with increased nonrelapse mortality through 1 year (hazard ratio, 0.77; 95% confidence interval, 0.59-1.00; P = .05). AlloHCT recipients all had significantly fewer mast cells, even those without GVHD compared with those with IBD (median, 59 vs 119; P &amp;lt; .01). The median number of GIT mast cells was also significantly lower in patients who received myeloablative conditioning (61.5 cells) than in those who received reduced intensity conditioning (78 cells) in the entire study population (P = .02). We conclude that GIT mast cells are depleted in all alloHCT patients, more prominently in those receiving myeloablative conditioning and those with severe GIT GVHD. Our novel findings warrant further investigation into the biological effects of mast cells in GIT GVHD.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001793","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T15:31:32Z","timestamp":1590507092000},"page":"2317-2324","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-6213","authenticated-orcid":false,"given":"Celalettin","family":"Ustun","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN;"},{"name":"Division of Hematology, Oncology and Cellular Therapy, Rush University, Chicago, IL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4667-0176","authenticated-orcid":false,"given":"Todd E.","family":"DeFor","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6078-5944","authenticated-orcid":false,"given":"Fatma K.","family":"Karadag","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN;"},{"name":"Department of Hematology, Ege University Hospital, Izmir, Turkey; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun","family":"Don Yun","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN;"},{"name":"Division of Hematology, Oncology and Cellular Therapy, Rush University, Chicago, IL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Nathan","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology and Cellular Therapy, Rush University, Chicago, IL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio G.","family":"Brunstein","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce R.","family":"Blazar","sequence":"first","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8078-8579","authenticated-orcid":false,"given":"Daniel J.","family":"Weisdorf","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5054-9419","authenticated-orcid":false,"given":"Shernan G.","family":"Holtan","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Amin","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"key":"2020052611305905000_B1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/asheducation-2007.1.62","article-title":"GVHD the nuts and bolts","volume":"2007","author":"Weisdorf","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"2020052611305905000_B2","first-page":"111","article-title":"Graft-versus-host disease","volume":"52","author":"Choi","year":"2010","journal-title":"Panminerva Med"},{"issue":"22","key":"2020052611305905000_B3","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"2020052611305905000_B4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molimm.2014.01.018","article-title":"Mast cell progenitors: origin, development and migration to tissues","volume":"63","author":"Dahlin","year":"2015","journal-title":"Mol Immunol"},{"issue":"4","key":"2020052611305905000_B5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1152\/physrev.1997.77.4.1033","article-title":"Mast cells","volume":"77","author":"Metcalfe","year":"1997","journal-title":"Physiol Rev"},{"issue":"9","key":"2020052611305905000_B6","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.leukres.2011.05.006","article-title":"Tyrosine kinase inhibitors in the treatment of systemic mastocytosis","volume":"35","author":"Ustun","year":"2011","journal-title":"Leuk Res"},{"issue":"2-4","key":"2020052611305905000_B7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000024041","article-title":"Stem cell factor-dependent survival, proliferation and enhanced releasability of purified mature mast cells isolated from human intestinal tissue","volume":"118","author":"Bischoff","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"key":"2020052611305905000_B8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3389\/fimmu.2015.00620","article-title":"Mast cell: A multi-functional master cell","volume":"6","author":"Krystel-Whittemore","year":"2016","journal-title":"Front Immunol"},{"issue":"4","key":"2020052611305905000_B9","doi-asserted-by":"crossref","first-page":"e1002619","DOI":"10.1371\/journal.ppat.1002619","article-title":"The role of mast cells in the defence against pathogens","volume":"8","author":"Urb","year":"2012","journal-title":"PLoS Pathog"},{"issue":"4","key":"2020052611305905000_B10","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.4049\/jimmunol.169.4.2044","article-title":"Key role for mast cells in nonatopic asthma","volume":"169","author":"Kraneveld","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"2020052611305905000_B11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0091-6749(97)70195-7","article-title":"Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness","volume":"100","author":"Foresi","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Pt 2","key":"2020052611305905000_B12","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1164\/ajrccm\/150.5_Pt_2.S39","article-title":"Mast cells and airway inflammation in asthma","volume":"150","author":"Wasserman","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2020052611305905000_B13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1365-2222.2003.01588.x","article-title":"Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma","volume":"33","author":"Masuda","year":"2003","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"2020052611305905000_B14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/thorax.57.8.677","article-title":"Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma","volume":"57","author":"Carroll","year":"2002","journal-title":"Thorax"},{"issue":"3","key":"2020052611305905000_B15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.192.3.455","article-title":"Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice","volume":"192","author":"Williams","year":"2000","journal-title":"J Exp Med"},{"issue":"1","key":"2020052611305905000_B16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbadis.2011.06.013","article-title":"The two faces of mast cells in food allergy and allergic asthma: the possible concept of Yin Yang","volume":"1822","author":"Kraneveld","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2020052611305905000_B17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/1523-1747.ep12373016","article-title":"Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease","volume":"102","author":"Murphy","year":"1994","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2020052611305905000_B18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2249.1995.tb03733.x","article-title":"Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts","volume":"100","author":"Nagler","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2020052611305905000_B19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0091-6749(92)90316-T","article-title":"Effect of coculture of rodent mast cells with murine chronic graft-versus-host disease (cGVHD)-derived fibroblasts","volume":"89","author":"Levi-Schaffer","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"2020052611305905000_B20","first-page":"641","article-title":"Mast cells in murine graft-versus-host disease: a model of immunologically induced fibrosis","volume":"46","author":"Choi","year":"1989","journal-title":"Immunol Ser"},{"issue":"2","key":"2020052611305905000_B21","first-page":"281","article-title":"Gut mucosal mast cells and goblet cells during acute graft-versus-host disease in rats","volume":"137D","author":"Levy","year":"1986","journal-title":"Ann Inst Pasteur Immunol"},{"issue":"22","key":"2020052611305905000_B22","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1182\/blood-2013-08-519157","article-title":"Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells","volume":"122","author":"Leveson-Gower","year":"2013","journal-title":"Blood"},{"issue":"21","key":"2020052611305905000_B23","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.4161\/cc.8.21.9999","article-title":"Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin","volume":"8","author":"Wu","year":"2009","journal-title":"Cell Cycle"},{"issue":"8","key":"2020052611305905000_B24","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"8","key":"2020052611305905000_B25","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2007-04-067215","article-title":"Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease","volume":"110","author":"Brunstein","year":"2007","journal-title":"Blood"},{"issue":"12","key":"2020052611305905000_B26","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"446","key":"2020052611305905000_B27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"1\/2","key":"2020052611305905000_B28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2307\/2333011","article-title":"A distribution-free k-sample test against ordered alternatives","volume":"41","author":"Jonckheere","year":"1954","journal-title":"Biometrika"},{"issue":"1","key":"2020052611305905000_B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.1996.262309.x","article-title":"Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease","volume":"28","author":"Bischoff","year":"1996","journal-title":"Histopathology"},{"issue":"7106","key":"2020052611305905000_B30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature05010","article-title":"Mast cells are essential intermediaries in regulatory T-cell tolerance","volume":"442","author":"Lu","year":"2006","journal-title":"Nature"},{"issue":"7016","key":"2020052611305905000_B31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature03085","article-title":"Mast cells promote homeostasis by limiting endothelin-1-induced toxicity","volume":"432","author":"Maurer","year":"2004","journal-title":"Nature"},{"issue":"5786","key":"2020052611305905000_B32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1126\/science.1128877","article-title":"Mast cells can enhance resistance to snake and honeybee venoms","volume":"313","author":"Metz","year":"2006","journal-title":"Science"},{"issue":"2 suppl 2","key":"2020052611305905000_B33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbmt.2004.11.005","article-title":"Regulatory T cells","volume":"11","author":"Blazar","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"19","key":"2020052611305905000_B34","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1182\/blood-2011-07-365817","article-title":"Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?","volume":"118","author":"Ustun","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2020052611305905000_B35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1034\/j.1600-065X.2001.1820113.x","article-title":"The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance","volume":"182","author":"Zelenika","year":"2001","journal-title":"Immunol Rev"},{"issue":"12","key":"2020052611305905000_B36","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.20012097","article-title":"Identification of regulatory T cells in tolerated allografts","volume":"195","author":"Graca","year":"2002","journal-title":"J Exp Med"},{"issue":"10","key":"2020052611305905000_B37","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"issue":"4","key":"2020052611305905000_B38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/icb.2009.117","article-title":"IL-10 is required for human CD4(+)CD25(+) regulatory T cell-mediated suppression of xenogeneic proliferation","volume":"88","author":"Sun","year":"2010","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"2020052611305905000_B39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1189\/jlb.1011510","article-title":"Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease","volume":"91","author":"Tawara","year":"2012","journal-title":"J Leukoc Biol"},{"issue":"45","key":"2020052611305905000_B40","first-page":"678","article-title":"Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease","volume":"49","author":"Nishida","year":"2002","journal-title":"Hepatogastroenterology"},{"issue":"7","key":"2020052611305905000_B41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/gut.31.7.791","article-title":"Histamine release from gut mast cells from patients with inflammatory bowel diseases","volume":"31","author":"Nolte","year":"1990","journal-title":"Gut"},{"issue":"1","key":"2020052611305905000_B42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0016-5085(90)91238-2","article-title":"Enhancement of human intestinal mast cell mediator release in active ulcerative colitis","volume":"99","author":"Fox","year":"1990","journal-title":"Gastroenterology"},{"issue":"1","key":"2020052611305905000_B43","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/ncomms2023","article-title":"Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors","volume":"3","author":"Kurashima","year":"2012","journal-title":"Nat Commun"},{"issue":"1","key":"2020052611305905000_B44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1073\/pnas.1005758108","article-title":"Essential role for mast cell tryptase in acute experimental colitis","volume":"108","author":"Hamilton","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2020052611305905000_B45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.immuni.2012.09.023","article-title":"Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor","volume":"38","author":"Zaiss","year":"2013","journal-title":"Immunity"},{"issue":"27","key":"2020052611305905000_B46","first-page":"9106","article-title":"Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12","key":"2020052611305905000_B47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/s41419-018-1223-4","article-title":"Mast cells are essential intermediaries in regulating IL-33\/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons","volume":"9","author":"He","year":"2018","journal-title":"Cell Death Dis"},{"issue":"2","key":"2020052611305905000_B48","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"issue":"8","key":"2020052611305905000_B49","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","article-title":"Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines","volume":"90","author":"Hill","year":"1997","journal-title":"Blood"},{"issue":"4","key":"2020052611305905000_B50","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bmt.2014.293","article-title":"Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation","volume":"50","author":"Nakasone","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"2020052611305905000_B51","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3389\/fimmu.2019.02470","article-title":"Mast cells are mediators of fibrosis and effector cell recruitment in dermal chronic graft-vs.-host disease","volume":"10","author":"Strattan","year":"2019","journal-title":"Front Immunol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/10\/2317\/1732378\/advancesadv2020001793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/10\/2317\/1732378\/advancesadv2020001793.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T15:32:13Z","timestamp":1590507133000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/10\/2317\/456145\/Tissue-mast-cell-counts-may-be-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,5,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001793","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]}}}